Novavax (NASDAQ:NVAX) Upgraded at StockNews.com
Novavax (NASDAQ:NVAX – Get Free Report) was upgraded by equities research analysts at StockNews.com from a “sell” rating to a “hold” rating in a research note issued on Friday. Separately, HC Wainwright reaffirmed a “buy” rating and set a $35.00 price objective on shares of Novavax in a report on Thursday, August 10th. Get Our […]